Higher light exposure at night and poor sleep quality are associated with poorer mental health outcomes.
Lilly’s anti-tau pill for Alzheimer’s fails in Phase 2 study
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS